Recent studies in humans and in rodent models of insulin resistance, diabetes and obesity implicate an important role for insulin/IGF-I signaling in β-cell biology [9], [13], [33], [39], [40], [41], [44], [46]. This evidence concerns the gene IGF1 and obesity disorder.